In conclusion, the implementation of advanced neuroimaging in unselected AIS patients receiving reperfusion monotherapy with IVT, results in an increase of tPA administration rates without delaying door-to-needle time and without raising safety or effectiveness concerns. The gene discussed is PLAT; the disease is androgen insensitivity syndrome.